Skip to content

Postoperative Pain Control & Relief in Neonates

Postoperative Pain Control & Relief in Neonates

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03677830
Acronym
POPCORN
Enrollment
11
Registered
2018-09-19
Start date
2019-04-19
Completion date
2024-03-07
Last updated
2024-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use, Pain, Postoperative, Premature Infant

Brief summary

Pain control for newborns has made significant improvements over the last 30 years. The use of narcotics remains the standard of care for neonates undergoing minor and major surgeries. Narcotics, however, are associated with adverse effects such as respiratory depression, prolonged intubation and withdrawal symptoms. Acetaminophen (Tylenol©) has been proposed as an adjunct to reduce narcotic use but current evidence from well designed studies in newborns and premature infants is limited. This study will randomly assign neonates undergoing a surgery to either morphine plus acetaminophen or morphine alone for pain control. The subjects will be followed for 72 hours after the operation and evaluate the benefits of acetaminophen for pain control.

Interventions

DRUGAcetaminophen

Scheduled intravenous acetaminophen for post-operative pain to minimize opiate exposure.

DRUGSaline

Intravenous saline will be administered at appropriate volume and schedule for control group as a placebo.

Sponsors

St. Louis University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

The intervention (intravenous acetaminophen) and placebo (saline) will be distributed by the pharmacy and are visually indistinguishable.

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Months
Healthy volunteers
Yes

Inclusion criteria

* All neonates ≥ 28 weeks of gestation and \<44 weeks of gestation undergoing general surgery procedures (below) and managed postoperatively in the Neonatal Intensive Care Unit (NICU). Minor procedures Inguinal hernia repair Laparoscopic or open gastrostomy tube placement Peritoneal drain placement for spontaneous intestinal perforation Gastroschisis bedside patch closure Major procedures Laparoscopic or open Nissen fundoplication, duodenal atresia repair, Hirschsprung pull through, Ladd's procedure or excision of abdominal cyst Thoracoscopy or thoracotomy procedure Enterostomy or colostomy creation Exploratory laparotomy Revision or closure of enterostomy or colostomy Any Gastroschisis or omphalocele repair in operating room Repair or staged repair of congenital anorectal malformations Resection of sacrococcygeal teratoma

Exclusion criteria

* Any infant admitted with preoperative diagnosis of neonatal abstinence syndrome (NAS) or known intrauterine opiate exposure * Any diagnosis of hepatitis exclusive of TPN-related biliary cholestasis * Renal disease with creatinine \>2.0 mg/dl at enrollment * Intraventricular hemorrhage grade 3 or greater, or cerebellar hemorrhage * Any patient with myotonic dystrophy or other congenital disease limiting validity of pain scoring * Opiate exposure within 14 days of operative procedure * Non-English-speaking parents/guardians

Design outcomes

Primary

MeasureTime frameDescription
Total morphine exposure72 hours following surgical procedureTotal amount of morphine received by infants for pain control post-operatively in mg/kg

Secondary

MeasureTime frameDescription
Total as needed morphine exposure72 hours following surgical procedureTotal as needed or prn doses of morphine received by infants for pain control post-operatively in mg/kg

Other

MeasureTime frameDescription
Time to full enteral feedsup to 8 weeksNumber of hours/days until receiving all nutritional support enterally following surgical procedure
Apnea of >20 seconds72 hours following surgical procedureApnea episodes of \>20 seconds documented by nursing staff after surgical procedure
Incidence of opiate withdrawal symptomsup to 8 weeksNumber of infants that develop withdrawal symptoms from opiate exposure
Time to endotracheal extubationup to 2 weeksNumber of hours from surgical procedure to endotracheal extubation
Time to first feedup to 2 weeksNumber of hours to first enteral feeding after surgical procedure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026